WHO recommends two new drugs for COVID-19 treatments amid Omicron surge
Zee News
"Today`s recommendations are based on new evidence from seven trials involving over 4,000 patients with non-severe, severe, and critical covid-19 infection," the group said in the British Medical Journal.
Geneva: The World Health Organization (WHO) Guideline Development Group recommended the use of two arthritis drugs called baricitinib and interleukin-6 (IL-6) in combination with corticosteroids to treat patients with severe or critical COVID-19, on Friday (January 14, 2022).
"Today`s recommendations are based on new evidence from seven trials involving over 4,000 patients with non-severe, severe, and critical covid-19 infection," the group said in the British Medical Journal, reported Sputnik.
Trials showed that a combination of corticosteroids with baricitinib and IL-6 - drugs of the Janus kinase inhibitor (JAK) group used to treat rheumatoid arthritis - improves the survival rate and reduces the need for pulmonary ventilation, with no increased adverse effects.
